Generate a tailored SOP for Dr. Marissa Rashkovan. Improve your application with a focused, well-structured draft.
Marissa Rashkovan earned her Bachelor of Science in Biochemistry from McGill University in 2010. She then pursued her PhD under Dr. Tarik Möröy at the IRCM in Experimental Medicine at McGill University, completing her doctorate in 2016, where she studied the role of the transcription factor Miz-1 in T cell development. Following her doctoral studies, she joined Dr. Adolfo Ferrando's team at Columbia University in New York, focusing on the metabolism of immature T cell leukemias (ETP-ALL) and the role of cholesterol in their development. In 2023, she became an assistant professor at the CHU Sainte-Justine research center and the Department of Pathology and Cell Biology, where her lab investigates the metabolic vulnerabilities of leukemias. Her research aims to identify new therapeutic targets to treat acute T cell leukemia and characterize the metabolic pathways utilized by T cell precursors.
CHU Sainte-Justine • Montréal, QC
Researching the metabolic vulnerabilities of leukemias.
Most programs require French B2 level; specific departments may require C1 or C2.